Company overview
DeSci Labs provides DeSci Publish, an open-access platform for researchers to share manuscripts, datasets, and code with AI-powered insights, version control, and blockchain-verified attestations. It supports the full research lifecycle from data management to publication without paywalls, enhancing transparency and impact in life sciences and pharma R&D. Founded in Switzerland, the company builds Web3-based infrastructure for FAIR-compliant, persistent research outputs.
DeSci Labs is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include desci labs, open access publishing, ai research tools, blockchain science, desci publish, fair data platform.
Structured facts
- Website
- https://www.desci.com
- Markets served
- United States & Americas
- Keywords
- desci labs, open access publishing, ai research tools, blockchain science, desci publish, fair data platform
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
Frequently asked questions
- What core capabilities does DeSci Labs offer for research publishing?
- DeSci Publish enables sharing of manuscripts, datasets, and code with DOIs, 100GB free storage, AI analytics, version control, and collaboration tools for open-access preprints.
- What regulatory or compliance features are included?
- The platform uses blockchain-verified attestations for research validation, ensures FAIR data principles by design, and provides long-term persistence on a peer-to-peer network without paywalls or publication charges.
- What geographies does DeSci Labs serve?
- Founded in Switzerland in 2021, DeSci Labs operates globally as a Web3-based platform accessible worldwide to researchers, with no geographic restrictions mentioned.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
